Devon Energy heads into the back half of May with its stock up 6.2% on the week and analysts raising targets — yet insiders are cashing out at pace, creating the week's sharpest tension.
The insider activity is hard to ignore. Director Thomas Jorden sold roughly 152,000 shares on May 15 alone, raising over $7.5 million across four transactions at $49.49. Executive VP Jeffrey Ritenour sold 70,000 shares on May 11 for $3.3 million. SVP Adam Vela added another $1.1 million sale on May 14. The net 90-day insider figure is positive in share terms, but the recent cluster of high-value sales — all executed as the stock climbed through the $46–$50 range — reads as distribution into strength rather than conviction buying. None of these carry high significance scores, which suggests routine planned selling rather than distress, but the timing against a six-week, 12% price run is worth noting.
The short-side story continues the direction flagged in Monday's note: bears are retreating. Short interest has slipped a further 8.6% on the week to roughly 4.9% of free float — the trend that began near 6% in early May is intact. The ORTEX short score has declined steadily from 39.6 on May 6 to 31.8 now, reflecting reduced conviction on the short side. Cost to borrow has ticked back up modestly to 0.41% from the 0.28% low seen last week, but remains firmly in easy-borrow territory. Availability is effectively unlimited — the lending pool is wide open, a dramatic reversal from the tighter conditions seen around May 7. Options traders remain bullish. The put/call ratio at 0.36 is near its 52-week low of 0.34, running well below its 20-day average of 0.42 and nearly one standard deviation below the mean. Calls are dominating flow.
The Street has turned more constructive in tandem with the price move. Citigroup's Scott Gruber raised his target to $65 on May 20 — maintaining his Buy — after lifting it from $44 to $60 just seven weeks earlier. Wells Fargo nudged its Overweight target to $68 on May 18. The consensus mean target now sits at $60.04, implying roughly 21% upside to the current $49.69 close. UBS trimmed its target slightly in April but kept its Buy. The lone holdout is Scotiabank, sitting at Sector Perform with a $46 target — below the current price. Valuation has re-rated with the stock: the P/E has expanded nearly a full turn over the past month to 9.6x, and EV/EBITDA has compressed as enterprise value moves alongside earnings upgrades. The dividend score ranks in the 89th percentile, a structural positive for yield-sensitive holders.
The institutional picture adds context to the insider selling. GQG Partners, Wellington Management, and Invesco all appear as new or significantly expanded holders in the latest reported period — each adding millions of shares. EnCap added 10.6 million shares. That institutional accumulation likely absorbed some of the insider supply coming to market in May, and helps explain why the stock has continued higher despite the selling pressure from management.
The recent earnings reaction is a live reminder of downside risk. Devon fell 11% on May 6 after Q1 results, then recovered meaningfully over the following weeks to post the 35% year-to-date gain referenced in recent notes. The next earnings date is August 4. Between now and then, the dynamic to track is whether institutional buyers maintain their appetite at current prices — and whether the insider selling cluster continues as the stock tests the $50 level.
See the live data behind this article on ORTEX.
Open DVN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
